Scientists map genetic blueprint of bile duct cancers in taiwan

NCT ID NCT05036486

Ongoing Knowledge-focused Sponsor: National Health Research Institutes, Taiwan Source: ClinicalTrials.gov ↗

Summary

This study is creating a detailed registry of genetic information and treatment outcomes from 480 patients with advanced biliary tract cancer in Taiwan. Researchers will analyze tumor tissue samples to identify genetic patterns that could help match patients to future targeted therapies or clinical trials. The goal is to build a comprehensive database to advance precision medicine for this difficult-to-treat cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Chang Gung Memorial Hospital, Chiayi

Chiayi City, Taiwan
China Medical University Hospital

Taichung, Taiwan
Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital,

Kaohsiung City, Taiwan
Koo Foundation Sun Yat-Sen Cancer Center

Taipei, Taiwan
Linko Chang Gung Memorial Hospital

Taoyuan District, Taiwan
MacKay Memorial Hospital

Taipei, Taiwan
National Cheng Kung University Hospital

Tainan, Taiwan
National Taiwan University Hospital

Taipei, Taiwan
Taipei Medical University-Shuang Ho Hospital

Taipei, Taiwan
Taipei Veterans General Hospital

Taipei, Taiwan
Taoyuan General Hospital, Ministry of Health and Welfare

Taoyuan District, Taiwan
Tri-Service General Hospital

Taipei, Taiwan

Conditions

Explore the condition pages connected to this study.

BILIARY TRACT CANCER (BTC)